FutureChem Co.,Ltd (220100.KQ)
KRW 18200.0
(0.94%)
KRW 18200.0
(0.94%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -303.61 KRW | 58.52% |
| 2022 | -732.02 KRW | -295.86% |
| 2021 | -184.92 KRW | 89.8% |
| 2020 | -1813.47 KRW | -263.68% |
| 2019 | -498.65 KRW | 55.81% |
| 2018 | -1128.33 KRW | -164.51% |
| 2017 | -426.58 KRW | 90.22% |
| 2016 | -4360.97 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -84.75 KRW | -9.89% |
| 2024 Q2 | -156.36 KRW | -84.5% |
| 2023 FY | - KRW | 58.52% |
| 2023 Q2 | -106.04 KRW | -142.27% |
| 2023 Q3 | -76.68 KRW | 27.69% |
| 2023 Q4 | -77.12 KRW | -0.57% |
| 2023 Q1 | -43.77 KRW | 81.41% |
| 2022 Q2 | -114.72 KRW | 23.95% |
| 2022 FY | - KRW | -295.86% |
| 2022 Q4 | -235.44 KRW | -10.3% |
| 2022 Q3 | -213.45 KRW | -86.06% |
| 2022 Q1 | -150.85 KRW | -72.12% |
| 2021 Q3 | -105.58 KRW | 0.0% |
| 2021 Q4 | -87.64 KRW | 16.99% |
| 2021 FY | - KRW | 89.8% |
| 2020 FY | - KRW | -263.68% |
| 2019 FY | - KRW | 55.81% |
| 2018 FY | - KRW | -164.51% |
| 2017 FY | - KRW | 90.22% |
| 2016 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | -666.05 KRW | 54.416% |
| CMG Pharmaceutical Co., Ltd. | 46.00 KRW | 760.022% |
| Celltrion Pharm, Inc. | 539.00 KRW | 156.328% |
| Huons Global Co., Ltd. | 3133.85 KRW | 109.688% |
| DongKook Pharmaceutical Co., Ltd. | 1073.13 KRW | 128.292% |
| Enzychem Lifesciences Corporation | -109.81 KRW | -176.487% |
| Humedix Co., Ltd. | 2512.11 KRW | 112.086% |
| Boditech Med Inc. | 1181.00 KRW | 125.708% |
| EuBiologics Co., Ltd. | -381.00 KRW | 20.312% |
| Huons Co., Ltd. | 4261.00 KRW | 107.125% |
| BNC Korea Co., Ltd. | 388.00 KRW | 178.25% |
| AptaBio Therapeutics Inc. | -540.91 KRW | 43.871% |